ARCHIVES

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Peer Review: Consumer Advocates Named To Panels Reviewing Center Grants, ECOG Renewal

September 4, 1998

DCPC Board Approves Concept for New Nutrition Grants

February 10, 1989

Organ Systems Coordinating Center Deadline Extended

August 5, 1983

No Issue Next Week

August 22, 1980

NKTR-102 Shows 29 Percent Response in Phase II Study

September 30, 2011

NCAB Agrees With NCI Recommendation To Drop PO1 Chartered Committees, Adopt Single Review

February 13, 1987